MongoDB Sinks Nearly 10% as Director Stock Sales Pile on to Leadership Worries, Pushing Shares Below Their 200-Day Average

MongoDB (MDB) shares fell sharply on Friday, Oct. 16, after filings showed two directors sold stock under pre-arranged trading plans. The stock traded at $330.26 as of 1:26 p.m. ET, down $36.23 or 9.89% from Thursday’s close of $366.49, and below its 200-day moving average of about $341. The sales themselves are modest, and there was no new company-specific announcement that we could find, so the selloff looks like a stock with a leadership question hanging over it reacting to a small piece of bad news, on a day when technology stocks were broadly weak.

What the insiders sold

All three sales were made under Rule 10b5-1 plans, which are set up in advance and are designed to remove timing discretion from insider trades. Agrawal’s sale cut her holding by nearly 19%, which is the figure drawing attention, but it was only 1,000 shares and she still holds about 4,300. Merriman, a co-founder, sold 4,000 shares across two days and still holds about 449,000 shares, worth roughly $148 million at Friday’s price. In total the three sales were worth about $1.86 million, a rounding error against a company with a market value of roughly $27 billion. Investors still read insider selling as a sentiment signal, particularly when the stock is already weak, but there is little in these filings that points to a change in the business.

The bigger overhang: a surprise CEO exit

The more important story is leadership. On Sept. 28, MongoDB announced that CEO Chirantan “CJ” Desai had stepped down effective immediately to take a senior role at Meta Platforms, and that Dev Ittycheria, who ran the company from 2014 to 2025, would return as interim president and CEO. Ittycheria grew annual revenue from about $35 million to more than $2.3 billion in that stretch. The board has hired an executive search firm to find a permanent chief executive, and the company reaffirmed the third-quarter and full-year guidance it gave on Sept. 1.

The stock fell roughly 16% to 17% on the news, to around $349 by one report. It recovered to close Thursday at $366.49 and then gave back nearly 10% on Friday to about $330. That puts MDB well under its 50-day average of about $396 and below its 200-day average of about $341, a technical line that traders often watch as a dividing line between an uptrend and a downtrend.

The business is still growing

Operationally, the last report was strong. Revenue grew 30%, Atlas grew 29%, margins widened by nine points and free cash flow roughly doubled, and MongoDB raised its full-year outlook. The company ended the quarter with about $2.4 billion in cash and investments and more than 70,600 customers. That contrast, strong numbers with a shaky leadership story, helps explain why the analyst consensus remains positive.

What Wall Street thinks

The consensus rating is Moderate Buy, with 2 Strong Buy, 28 Buy and 7 Hold ratings and an average price target of about $463. Recent calls include RBC at Outperform with a $465 target (Sept. 30), Wells Fargo at Overweight with a $475 target raised from $375 (Aug. 25), Bernstein at Outperform with a $484 target raised from $449 (Sept. 2), Monness Crespi at Buy with a $500 target raised from $460 (Sept. 2), and Evercore reaffirming Outperform (Sept. 24). Several of these targets were set before the CEO change and the latest leg down.